First Wave BioPharma Inc (FWBI)
2.74
+0.01
(+0.37%)
USD |
NASDAQ |
Apr 26, 16:00
2.82
+0.08
(+2.92%)
After-Hours: 20:00
First Wave BioPharma Enterprise Value: 2.450M for April 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 2.450M |
| April 25, 2024 | 2.430M |
| April 24, 2024 | 3.017M |
| April 23, 2024 | 3.220M |
| April 22, 2024 | 2.794M |
| April 19, 2024 | 2.166M |
| April 18, 2024 | 2.653M |
| April 17, 2024 | 2.774M |
| April 16, 2024 | 3.017M |
| April 15, 2024 | 3.523M |
| April 12, 2024 | 3.625M |
| April 11, 2024 | 3.827M |
| April 10, 2024 | 3.827M |
| April 09, 2024 | 4.293M |
| April 08, 2024 | 4.556M |
| April 05, 2024 | 4.921M |
| April 04, 2024 | 5.184M |
| April 03, 2024 | 4.961M |
| April 02, 2024 | 5.164M |
| April 01, 2024 | 5.488M |
| March 28, 2024 | 5.771M |
| March 27, 2024 | 4.901M |
| March 26, 2024 | 4.741M |
| March 25, 2024 | 5.037M |
| March 22, 2024 | 5.629M |
| Date | Value |
|---|---|
| March 21, 2024 | 5.748M |
| March 20, 2024 | 6.044M |
| March 19, 2024 | 6.478M |
| March 18, 2024 | 6.518M |
| March 15, 2024 | 6.261M |
| March 14, 2024 | 7.505M |
| March 13, 2024 | 9.796M |
| March 12, 2024 | 5.778M |
| March 11, 2024 | 6.075M |
| March 08, 2024 | 7.559M |
| March 07, 2024 | 8.091M |
| March 06, 2024 | 8.544M |
| March 05, 2024 | 9.106M |
| March 04, 2024 | 7.888M |
| March 01, 2024 | 11.34M |
| February 29, 2024 | 9.217M |
| February 28, 2024 | 8.765M |
| February 27, 2024 | 7.672M |
| February 26, 2024 | 6.173M |
| February 23, 2024 | 6.048M |
| February 22, 2024 | 4.862M |
| February 21, 2024 | 4.644M |
| February 20, 2024 | 4.971M |
| February 16, 2024 | 5.065M |
| February 15, 2024 | 4.940M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-0.9703M
Minimum
Dec 18 2023
114.44M
Maximum
Mar 16 2021
19.86M
Average
13.22M
Median
Dec 27 2021
Enterprise Value Benchmarks
| BioVie Inc | 9.298M |
| Jaguar Health Inc | 81.03M |
| Benitec Biopharma Inc | -2.486M |
| Immuneering Corp | -42.08M |
| NovaBay Pharmaceuticals Inc | 2.329M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.101M |
| Total Expenses (Quarterly) | 4.094M |
| EPS Diluted (Quarterly) | -2.676 |
| Earnings Yield | -11.11K% |